Amyotrophic lateral sclerosis care and research in the United States during the COVID‐19 pandemic: Challenges and opportunities
- 23 May 2020
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 62 (2), 182-186
- https://doi.org/10.1002/mus.26989
Abstract
COVID‐19 has created unprecedented challenges for amyotrophic lateral sclerosis (ALS) clinical care and research in the United States. Traditional evaluations for making an ALS diagnosis, measuring progression, and planning interventions rely on in‐person visits that may now be unsafe or impossible. Evidence‐ and experience‐based treatment options such as multidisciplinary team care, feeding tubes, wheelchairs, home health and hospice have become more difficult to obtain and in some places are unavailable. Additionally, the pandemic has impacted ALS clinical trials by impairing the ability to obtain measurements for trial eligibility, to monitor safety and efficacy outcomes, and to dispense study drug since these also often rely on in‐person visits. We review opportunities for overcoming some of these challenges through telemedicine and novel measurements. These can re‐optimize ALS care and research in the current setting and during future events that may limit travel and face to face interactions.This publication has 29 references indexed in Scilit:
- Is firstly diagnosed ALS really ALS? Results of a population-based study with long-term follow-upAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2016
- A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern IrelandJournal of Neurology, Neurosurgery & Psychiatry, 2014
- Interstate Licensure for Telemedicine: The Time Has ComeThe AMA Journal of Ethic, 2014
- Single-breath counting: a pilot study of a novel technique for measuring pulmonary function in childrenThe American Journal of Emergency Medicine, 2011
- Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)Neurology, 2009
- Electrodiagnostic criteria for diagnosis of ALSClinical Neurophysiology, 2008
- Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trialAmyotrophic Lateral Sclerosis, 2007
- Multidisciplinary ALS care improves quality of life in patients with ALSNeurology, 2005
- Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000Journal of Neurology, Neurosurgery & Psychiatry, 2003
- El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2000